Gladstone Institutes launches COVID-19 fund

By The Science Advisory Board staff writers

April 3, 2020 -- Gladstone Institutes is seeking donations to mobilize resources and start research projects to help fight the COVID-19 pandemic.

The nonprofit lab in San Francisco will use donations to accelerate the most promising, necessary COVID-19 research. Gladstone has an established in-house team of virologists, stem cell researchers, medicinal chemists, geneticists, and artificial intelligence experts on hand to collaborate on developing diagnostics and targeted therapeutics for COVID-19.

If you like this content, please share it with a colleague!

Related Reading

SARS-CoV-2 vaccine utilizing microneedle arrays appears in the literature
Within four weeks of the SARS-CoV-2 spike sequence becoming available, researchers from the University of Pittsburgh School of Medicine developed immunogens...

Funding floodgates open for COVID-19 research
The impacts of the COVID-19 pandemic are being felt around the world. Researchers are working at a record-setting pace to understand the novel coronavirus...

CAS offers open-access chemical database for COVID-19
The Chemical Abstracts Service (CAS), a division of the American Chemical Society, announced it has released an open-access database of chemical compounds...

How AI is speeding development of COVID-19 therapies
As the world is facing a new challenge in trying to both adapt to and defend itself against the novel coronavirus, artificial intelligence (AI) is offering...

Viscient to bioprint lung tissues to accelerate COVID-19 research
Biotherapeutics company Viscient Biosciences said it, or a sister company to be funded and launched shortly using the same technology, will use 3D bioprinting...